Tizanidine
Back to searchMolecule Structure
Scientific Name
Tizanidine
Description of the Drug
Tizanidine is an alpha-2 adrenergic agonist used for the short-term treatment of muscle spasticity.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00697
http://www.drugbank.ca/drugs/DB00697
Brand Name(s)
Not Available
Company Owner(s)
Alkem Laboratories Ltd, Jubilant Generics Ltd, Sun Pharmaceutical Industries Inc, Mylan Pharmaceuticals Inc, Zydus Pharmaceuticals Usa Inc, Rubicon Research Private Ltd, Novast Laboratories Ltd, Aurobindo Pharma Ltd, Ani Pharmaceuticals Inc, Epic Pharma Llc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Adrenergic receptor alpha-2 | PROTEIN FAMILY | AGONIST | CHEMBL2095158 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL60334 | ||
| PharmGKB | PA451701 | ||
| Human Metabolome Database | HMDB0014835 | ||
| DrugBank | DB00697 | ||
| PubChem: Thomson Pharma | 15196825 | ||
| PubChem | 5487 | ||
| Mcule | MCULE-2342327042 | ||
| LINCS | LSM-5242 | ||
| Nikkaji | J11.180E | ||
| BindingDB | 50240671 | ||
| EPA CompTox Dashboard | DTXSID9023679 | ||
| DrugCentral | 2683 | ||
| Guide to Pharmacology | 7308 | ||
| rxnorm | ZANAFLEX | TIZANIDINE | TIZANIDINE HYDROCHLORIDE |
| KEGG Ligand | C07452 | ||
| ChEBI | 63629 | ||
| ZINC | ZINC000019702309 |
